Artículos por temáticas

Cortical thickness in visuo-motor areas is related to motor outcomes after STN DBS for Parkinson's disease

Frizon LA, Gopalakrishnan R, Hogue O, Floden D, Nagel SJ, Baker KB, Isolan GR, Stefani MA, Machado AG.

Parkinsonism Relat Disord. 2020 Feb;71:17-22. doi: 10.1016/j.parkreldis.2020.01.006. Epub 2020 Jan 17.

Immunotherapy for Parkinson's disease

Schwab AD, Thurston MJ, Machhi J, Olson KE, Namminga KL, Gendelman HE, Mosley RL.

Neurobiol Dis. 2020 Apr;137:104760. doi: 10.1016/j.nbd.2020.104760. Epub 2020 Jan 21.

WITHDRAWN: Genetics of Parkinson's disease

Lill CM.

Mol Cell Probes. 2020 Jan 21:101471. doi: 10.1016/j.mcp.2019.101471. Online ahead of print.

Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis

Gao J, Teng J, Liu Z, Cai M, Xie A.

Neurosci Lett. 2020 Feb 16;720:134778. doi: 10.1016/j.neulet.2020.134778. Epub 2020 Jan 21.

Improvement of classification performance of Parkinson's disease using shape features for machine learning on dopamine transporter single photon emission computed tomography

Shiiba T, Arimura Y, Nagano M, Takahashi T, Takaki A.

PLoS One. 2020 Jan 24;15(1):e0228289. doi: 10.1371/journal.pone.0228289. eCollection 2020.

Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson's disease

Gera A, O'Keefe JA, Ouyang B, Liu Y, Ruehl S, Buder M, Joyce J, Purcell N, Pal G.

PLoS One. 2020 Jan 24;15(1):e0226494. doi: 10.1371/journal.pone.0226494. eCollection 2020.

Retraction: DJ-1 Modulates α-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70

PLOS ONE Editors.

PLoS One. 2020 Jan 24;15(1):e0219023. doi: 10.1371/journal.pone.0219023. eCollection 2020.

Pierre D. and the first photographs of Parkinson's disease

Lewis PA, Plun-Favreau H, Rowley M, Spillane J.

Mov Disord. 2020 Mar;35(3):389-391. doi: 10.1002/mds.27965. Epub 2020 Jan 24.

Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease

Schneider SA, Alcalay RN.

J Neurol. 2020 Mar;267(3):860-869. doi: 10.1007/s00415-020-09705-7. Epub 2020 Jan 23.

Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson's disease in clinical middle stages

Huang J, Wang Q, Li K, Zhang Q, Xu G, Liu J, Zhang J, Niu T, Zhang Q, Luo W.

Neurol Sci. 2020 Jan 23. doi: 10.1007/s10072-020-04266-z. Online ahead of print.

Evaluating Mild Cognitive Dysfunction in Patients with Parkinson's Disease in Clinical Practice in Taiwan

Yu RL, Lee WJ, Li JY, Chang YY, Chen CC, Lin JJ, Sung YF, Lin TK, Fuh JL.

Sci Rep. 2020 Jan 23;10(1):1014. doi: 10.1038/s41598-020-58042-2.

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease

Kelly R, Joers V, Tansey MG, McKernan DP, Dowd E.

Molecules. 2020 Jan 21;25(3):453. doi: 10.3390/molecules25030453.

Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease

Chlebanowska P, Tejchman A, Sułkowski M, Skrzypek K, Majka M.

Int J Mol Sci. 2020 Jan 21;21(3):694. doi: 10.3390/ijms21030694.

Roflupram exerts neuroprotection via activation of CREB/PGC-1α signalling in experimental models of Parkinson's disease

Zhong J, Dong W, Qin Y, Xie J, Xiao J, Xu J, Wang H.

Br J Pharmacol. 2020 May;177(10):2333-2350. doi: 10.1111/bph.14983. Epub 2020 Feb 26.

Evaluation of Cognitive Function in Relation to Progression of Parkinson Disease

Yamawaki R, Nankaku M, Kusano Y, Tajima A, Ikeguchi R, Matsuda S.

Am J Phys Med Rehabil. 2020 Jul;99(7):626-629. doi: 10.1097/PHM.0000000000001385.